Evidence map›Paper›PMID 21909113›Full record

ArticleNature2011

CTCF-binding elements mediate control of V(D)J recombination.

Chunguang Guo, Hye Suk Yoon, Andrew Franklin, Suvi Jain, Anja Ebert, Hwei-Ling Cheng, Erica Hansen, Orion Despo, Claudia Bossen, Christian Vettermann and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

186 citing papers in PubMed, 1 synthesis or guideline pooled it, 268 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human VProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Chunguang GuoHoward Hughes Medical Institute, The Children's Hospital, The Immune Disease Institute, Department of Genetics, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.
Hye Suk Yoon
Andrew Franklin
Suvi Jain
Anja Ebert
Hwei-Ling Cheng
Erica Hansen
Orion Despo
Claudia Bossen
Christian Vettermann
Jamie G Bates
Nicholas Richards
Darienne Myers
Harin Patel
Michael Gallagher
Mark S Schlissel
Cornelis Murre
Meinrad Busslinger
Cosmas C Giallourakis
Frederick W Alt
Harvard University · USUniversity of California, Berkeley · USHoward Hughes Medical Institute · USResearch Institute of Molecular Pathology · ATUniversity of California, San Diego · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Mechanisms that Control IgH Variable Region Exon AssemblyR01AI020047 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI ALT, FREDERICK W. · 1985 to 2025
$14.1M
TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
The Regulation of B Lymphocyte DevelopmentR01HL048702 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SCHLISSEL, MARK S. · 1994 to 2011
$4.1M
E PROTEIN AND B CELL DIFFERENTIATIONR37CA054198 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 2001 to 2008
$3.5M
Biochemistry and Regulation of V(D)J RecombinationR37AI040227 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SCHLISSEL, MARK S. · 2005 to 2012
$3.0M
The role of E-proteins in B cell developmentR01CA054198 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 1991 to 2013
$2.2M
BIOCHEMISTRY AND REGULATION OF V(D)J RECOMBINATIONR01AI040227 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SCHLISSEL, MARK S. · 1996 to 2004
$1.5M
Genetic Analysis of VDJ Recombination RegulationK08AI070839 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GIALLOURAKIS, COSMAS C · 2006 to 2010
$647k
Howard Hughes Medical InstituteNCI NIH HHS CA054198-20NCI NIH HHS R01 CA054198NCI NIH HHS R37 CA054198NCI NIH HHS T32 CA009151NHLBI NIH HHS R01 HL048702NHLBI NIH HHS R01 HL48702NIAID NIH HHS AI40227NIAID NIH HHS K08 AI070839NIAID NIH HHS R01 AI020047NIAID NIH HHS R01 AI040227NIAID NIH HHS R01 AI20047NIAID NIH HHS R37 AI040227NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Immunoglobulin heavy chain (IgH) variable region exons are assembled from V(H), D and J(H) gene segments in developing B lymphocytes. Within the 2.7-megabase mouse Igh locus, V(D)J recombination is regulated to ensure specific and diverse antibody repertoires. Here we report in mice a key Igh V(D)J recombination regulatory region, termed intergenic control region 1 (IGCR1), which lies between the V(H) and D clusters. Functionally, IGCR1 uses CTCF looping/insulator factor-binding elements and, correspondingly, mediates Igh loops containing distant enhancers. IGCR1 promotes normal B-cell development and balances antibody repertoires by inhibiting transcription and rearrangement of D(H)-proximal V(H) gene segments and promoting rearrangement of distal V(H) segments. IGCR1 maintains ordered and lineage-specific V(H)(D)J(H) recombination by suppressing V(H) joining to D segments not joined to J(H) segments, and V(H) to DJ(H) joins in thymocytes, respectively. IGCR1 is also required for feedback regulation and allelic exclusion of proximal V(H)-to-DJ(H) recombination. Our studies elucidate a long-sought Igh V(D)J recombination control region and indicate a new role for the generally expressed CTCF protein.

Indexed as

AnimalsB-LymphocytesCCCTC-Binding FactorCell LineageChromosomes, MammalianDNA, IntergenicEnhancer Elements, GeneticFeedback, PhysiologicalGene Rearrangement, B-Lymphocyte, Heavy ChainGerm CellsImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionMiceMutationRecombination, GeneticRegulatory Sequences, Nucleic AcidCCCTC-Binding FactorCtcf protein, mouseDNA, IntergenicImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionRepressor Proteins

Identifiers

PMID21909113
PMCPMC3342812
OpenAlexW1980546626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.